Celeste F. Bové, M.A., CCC-A Senior Science Policy Analyst Office of Science Coordination & Communication Food and Drug Administration FDA Participation.

Slides:



Advertisements
Similar presentations
SECOND EXPERT GROUP MEETING ON BINASIA JANUARY 2006, BANGKOK COUNTRY REPORT: MONGOLIA Ts.Oyunsuren Center for Biotechnology, Institute of Biology,
Advertisements

21 st Century Science and Education for Global Economic Competition William Y.B. Chang Director, NSF Beijing Office NATIONAL SCIENCE FOUNDATION.
ESSENTIAL SERVICE 3: Inform, Educate, and Empower Individuals and Communities About Health Issues CLARK AND DUBOIS COUNTIES Local Public Health Workforce.
Felicia Barnett Ronald B. Landy USEPA Office of Research and Development Office of Science Policy Regional Science Program.
The Economic Benefits of Economic Peer Review Richard A. Williams, Ph.D. Director, Division of Market Studies Office of Scientific Analysis and Support.
Dr. Michael E. Oehlsen International Policy Analyst International Programs Team - Office of the Director Center for Veterinary Medicine Food and Drug Administration.
10 th October 2013 The delivery of 21 st century services – the implications for the evolution of the Healthcare Science workforce Joan Fletcher.
Lessons Learned in Initiating and Conducting Risk Assessments within a Risk Analysis Framework: A FDA/CFSAN Approach Robert Buchanan DHHS Food and Drug.
Health Line of Business Revised Health Domains January 26, 2005 Outcomes / Domains have been revised.
Introduction to Regulation
Becker Grand Rounds: Wally Pellerite June 30, 2011.
Overview of the Howard University Animal Care and Use Program (IACUC) Regulatory/Oversight Agencies OLAW (Office of Laboratory Animal Welfare) USDA (United.
Final Notes Fera/JIFSAN 2012 Robert Edwards Chief Scientist Food and Environment Research Agency (Fera)
Ohio Nano-Summit March 3, 2005 REGULATORY CONSIDERATIONS FOR NANOTECHNOLOGY IN PUBLIC HEALTH FOOD AND DRUG ADMINISTRATION Norris E. Alderson, Ph.D. Associate.
Medical Informatics Basics
1 Workshop 3: Health Lessons learned Finn Sheye EFSA Community agencies: Partners in Accession 26 November 2009, Sintra, Portugal.
The Changing Food Environment The Role and Activities of the U.S. Food and Drug Administration Transatlantic Consumer Dialogue The Changing Food Environment.
Predicting human dose-response relationships from multiple biological models: Issues with Cryptosporidium parvum Risk Assessment Consortium.
Best Practices in Multicultural Advocacy and Treatment Eliminating Disparities: Multicultural Strategic Summit NAMI.
Regulatory Update Ellen Leinfuss SVP, Life Sciences.
“Critical Path” for Food and Nutrition Science Board November 5, 2004 Alan M. Rulis.
Cross Border Animal Health Plan of Action – Kenya and Uganda Four Strategic areas 1. To improve prevention, management and control of cross border animal.
Center for Veterinary Medicine (CVM) RECALLS.  21 CFR 7.40 provides guidance on the policy, procedures, and industry responsibilities for recalls. 
Responding to Recalls LUHS uses new tool and team to quickly catch recalled medical devices, products and drugs Team Leaders: Jen Carlson, Environmental.
Physiologists & the FDA Kevin J. Greenlees, Ph.D., DABT Senior Advisor for Science & Policy Office of New Animal Drug Evaluation FDA Center for Veterinary.
Bioinformatics Education: Training a New Generation of Professionals Patricia Dombrowski May 2005.
INTRODUCTION TO RA.
EF on IST in FP6 in Greece Information Day Athens-Thessaloniki, December 2002 The IST Priority in FP6 Erastos Filos
National Center for Emerging and Zoonotic Infectious Diseases Centers for Disease Control June 14, 2011 : The Food Safety Modernization Act: Implications.
FDA Science Board Drug Safety Initiative April 15, 2005 Rockville, MD RADM Steven Galson, MD, MPH Acting Director, Center for Drug Evaluation and Research.
Public Health Programme Information Event June 2015 Kay Duggan-Walls, Health Research Board National Focal Point.
FAO/WHO CODEX TRAINING PACKAGE Enhancing participation in Codex activities Developed by the Food and Agriculture Organization of the United Nations (FAO)
Drug Transfer Into Breast Milk and Interpretation of Data Lawrence J. Lesko Office of Clinical Pharmacology and Biopharmaceutics Center for Drug Evaluation.
Component 6 - Health Management Information Systems Unit 1-2 What is Health Informatics?
Management of Change ► The health, safety, security, environmental, technical and other impacts of temporary and permanent changes are formally assessed,
1 U.S. Food and Drug Administration International Programs Melinda K. Plaisier Assistant Commissioner for International Programs U.S. Food and Drug Administration.
Public Health and Risk Assessment (2nd of 10 Lectures on Toxicologic Epidemiology) Michael H. Dong MPH, DrPA, PhD  readings.
Nanotechnology - USDA - 18 Nov 2002 REGULATORY CONSIDERATIONS FOR NANOTECHNOLOGY IN PUBLIC HEALTH FOOD AND DRUG ADMINISTRATION Norris E. Alderson, Ph.D.
Everywhere you look Health Science touches your life.
FDA Standards Development and Implementation Randy Levin, M.D. Director, Office of Information Management Center for Drug Evaluation and Research Food.
Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.
Agencies of the Executive Branch Decisions made by any agency of the Executive Branch are considered an executive order and have the power of LAW!!!
The Regulatory Science of Regenerative Medicine Celia M. Witten, Ph.D., M.D., Director Office of Cellular, Tissue and Gene Therapies Center for Biologics.
NACDD Hill Day: Legislative Visits What to Expect Mari T. Brick, MA Program Consultant, NACDD
Veterinary Laboratory Investigation and Response Network Renate Reimschuessel 1, Sarah Nemser 1, Andriy Tkachenko 1, Olgica Ceric 1, Jake Guag 1, David.
Title Page Quality Mo Samimi, Ph.D. CMQ/OE Presented at the ASQ Biomedical Division Northern California Discussion Group. May 2011.
Clinical Research Informatics [CRI]. Informatics, defined generally as the intersection of information and computer science with a health-related discipline,
Center for Biologics Evaluation and Research, FDA Site Visit Introduction Kathryn M. Carbone, M.D. Associate Director for Research.
Government Regulatory Agencies and Impact on Consumer Choices Presentation.
Karin L. Lightfoot Walden University. Objectives Upon completion of the presentation, the viewer will be able to: 1. Report the amount of bottled water.
Laurie E. Locascio, Ph.D. Director, MML/NIST NIST/MML: Measurement Assurance for Biological Systems.
Joint Health IT Committee Meeting Precision Medicine Task Force March 10, 2016 Leslie Kelly Hall, Co-Chair Andy Wiesenthal, Co-Chair.
The CDRH Software Message (October 19, 2002) John F Murray Jr.. Center for Devices & Radiological Health US Food and Drug Administration
Role of Community Health Educators. Lecture Objectives By the end of this lecture, you will be able to: Have a good understanding of the role of community.
The opportunities and challenges of sharing genomics data with the pharmaceutical industry Shahid Hanif, Head of Health Data & Outcomes, ABPI DNA digest.
Health Management Information Systems Consumer Health Informatics Lecture a This material Comp6_Unit8a was developed by Duke University, funded by the.
A New Look at Logic Modeling and ADRC Evaluation - The Georgia Experience Glenn M. Landers Amanda Phillips Martinez.
Everywhere you look Health Science touches your life.
FDA Perspective on Cardiovascular Device Development
CDRH 2010 Strategic Priorities
American Society for Quality Region 5 Quality Conference
Innovation: A Priority for FDA
Overview of FDA Food Inspections
PH Systems Require More than IT
Professional Organizations
Sacurima – CA Safety Culture and Risk Management in Agriculture.
Sacurima – CA Safety Culture and Risk Management in Agriculture.
What is FASEB? A federation of 30 societies
Nutrition. Good Food Health.
Office of Health, Safety and Security
Presentation transcript:

Celeste F. Bové, M.A., CCC-A Senior Science Policy Analyst Office of Science Coordination & Communication Food and Drug Administration FDA Participation in the Internet2 Community May 7, 2002

2 FDA Organization Center for Biologics Evaluation and Research Center for Devices and Radiological Health Center for Drug Evaluation and Research Center for Food Safety and Applied Nutrition Center for Veterinary Medicine National Center for Toxicological Research Office of Regulatory Affairs Office of the Commissioner

3 FDA Regulatory Science Focus Public health questions Better tools and methods New science, new technologies Information management Adeptness of scientific workforce Consumer information

4 New Science - New Technologies Genomics, proteomics Tissue products Robotics Biosensors, drug delivery systems Transgenics

5 Information Management Informatics Artificial intelligence tools Knowledge/ data management Computational science Risk Management

6 FDA - A Scientific Agency Training, retraining Communication among scientists

7 Consumer Information Freedom of choice, right to know Risk communication

8 Internet2 - Current Status =Ramp-up stage, i.e., disseminate information across the agency =Facilitate communication between and among interested scientists =Identify potential uses for Internet2 technology  Identify regulatory implications =Assess value to agency